Dow Up0.90% Nasdaq Up0.02%

Eli Lilly and Company (LLY)

-NYSE
66.64 Up 1.15(1.76%) 1:06PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 4,935,600   4,683,100   5,808,800   5,772,600  
Cost of Revenue1,189,700  1,222,700  1,386,500  1,198,100  
Gross Profit 3,745,900   3,460,400   4,422,300   4,574,500  
Operating Expenses
Research Development1,195,400  1,109,300  1,475,400  1,377,400  
Selling General and Administrative1,719,900  1,428,900  1,944,500  1,142,600  
Non Recurring -  31,400  92,500   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 830,600   890,800   909,900   2,054,500  
Income from Continuing Operations
Total Other Income/Expenses Net109,800   -   -  (541,100)
Earnings Before Interest And Taxes940,400  890,800  909,900  1,513,400  
Interest Expense -   -   -   -  
Income Before Tax940,400  890,800  909,900  1,513,400  
Income Tax Expense206,900  162,900  182,400  310,300  
Minority Interest -   -   -   -  
Net Income From Continuing Ops733,500  727,900  727,500  1,203,100  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 733,500   727,900   727,500   1,203,100  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 733,500   727,900   727,500   1,203,100  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.